Vertex Pharmaceuticals (VRTX)

Short-Term Investments

$1.71B

Quarterly · Period ending: · USD

VRTX logo

VRTX Short-Term Investments

Latest reported$1.71B
VRTX Quarterly Short-Term Investments ($0.00 → $1.71B)
High-resolution chart · PNG

VRTX short-term investments history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Vertex Pharmaceuticals Short-Term Investments — Quarterly (USD)
Period endingShort-Term Investments (USD)
1,708,900,000
1,753,800,000
1,523,300,000
1,347,400,000
1,410,600,000
1,526,500,000
1,546,300,000
1,285,300,000
1,215,400,000
1,013,300,000
849,200,000
818,000,000
1,085,200,000
1,124,200,000
274,500,000
599,200,000
551,200,000
638,000,000
729,900,000
685,187,000
644,315,000
619,638,000
670,710,000
792,971,000
619,437,000
596,984,000
698,972,000
598,390,000
656,538,000
584,150,000
518,108,000
577,583,000
622,396,000
481,124,000
423,254,000
427,282,000
445,520,000
405,103,000
250,612,000
408,749,000
465,570,000
421,373,000
327,694,000
249,580,000
145,907,000
516,255,000
761,847,000
759,174,000
798,603,000
900,155,000
895,777,000
839,469,000
899,449,000
860,255,000
831,808,000
861,656,000
769,273,000
712,944,000
493,602,000
116,140,000
135,296,000
376,916,000
788,214,000
633,110,000
641,537,000
696,136,000
838,255,000
297,477,000
345,415,000
266,987,000
442,986,000
377,191,000
282,430,000
258,947,000
105,208,000
248,571,000
424,249,000
300,812,000
491,455,000
211,324,000
220,911,000
257,632,000
283,112,000
297,546,000
251,911,000
296,961,000
337,314,000
381,390,000
396,676,000
467,567,000
485,005,000
518,155,000
499,986,000
499,316,000
526,886,000
547,760,000
554,577,000
522,801,000
553,997,000
185,915,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.